1. Ascher-Svanum H, et al.; Eli Lilly. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry 2006;67: 453–60.
2. Babiker IE. Noncompliance in schizophrenia. Psychiatr Dev 1986;4:329–37.
3. Brook O, et al. Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial. Eur Neuropsychopharmacol 2003;13:1–9.
4. Brown MT, et al. Medication adherence: WHO cares? Mayo Clin Proc 2011;86:304–14.
5. Cramer JA, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008;11:44–7.
6. Day JC, et al. Attitudes toward antipsychotic medication. The impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 2005;62:717–24.
7. DiMatteo M, et al. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101–7.
8. Gaebel W, et al. Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST). Eur Neuropsychopharmacol 2010;20:310–6.
9. Hogan TP, et al. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983;13:177–83.
10. Jin J, et al. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag 2008;4:269–86.
11. Joyce A, et al. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 1998;49:196–201.
12. Kampman O, et al. Compliance in psychoses. Acta Psychiatr Scand 1999;100:167–75.
13. Keck PE Jr, et al. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull 1997;33:87–91.
14. Keck PE Jr1, et al. Factors associated with pharmacologic noncompliance in patients with mania. J Clin Psychiatry 1996;57:292–7.
15. Lindstrom E, et al. Suicides during 7 years among a catchment area cohort of patients with psychoses. Nord J Psychiatry 2012;66: 8–13.
16. McEvoy JP, et al. Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients. J Nerv Ment Dis 1984;172:412–6.
17. Miller WR, et al. Motivational interviewing: Preparing people to change addictive behavior. New York: Guildford Press, 1991.
18. Moore PJ, et al. Psychosocial factors in medical and psychological treatment avoidance: the role of the doctor-patient relationship. J Health Psychol 2004;9:421–33.
19. Nielsen RE, et al. DAI-10 is as good as DAI-30 in schizophrenia. Eur Neuropsychopharmacol 2012;22:747–50.
20. Ponnusankar S, et al. Assessment of impact of medication counseling on patients’ medication knowledge and compliance in an outpatient clinic in South India. Patient Educ Couns 2004;54:55–60.
21. Pool VE, et al. A selected review of the literature and an empirical analysis of drug treatment compliance by schizophrenic patients. Int Rev Appl Psychol 1986;35:547–76.
22. Robinson D, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999;56:241–7.
23. Rubak S, et al. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 2005;55:305–12.
24. Seo MA, et al. Development of a structural model explaining medication compliance of persons with schizophrenia. Yonsei Med J 2005;46:331–40.
25. Townsend L, et al. Adolescent attitudes toward psychiatric medication: The utility of the drug attitude inventory. J Child Psychol Psychiatry 2009;50:1523–31.
26. Viswanathan M, et al. Medication adherence interventions: comparative effectiveness. Closing the quality gap: revisiting the state of the science. Evidence report No. 208. Rockville, MD: Agency for Healthcare Research and Quality. AHRQ Publication No. 12-E010-EF. RTI International – University of North Carolina, 2012.
27. Weiden PJ, et al. Partial compliance and risk of rehospitalization among california medicaid patients with schizophrenia. Psychiatr Serv 2004;55:886–91.
28. Zygmunt A, et al. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002;159:1653–64.
Sebastian Peter Lenhart, Apotheke des kbo-Isar-Amper-Klinikums München-Ost, Ringstraße 10, 85540 Haar, E-Mail: email@example.com
Lisa Kristina Blindzellner, Maximilian Benedikt Kuhn, München
Volker Lemsch, Prof. Dr. Dr. Margot Albus, M.Sc., kbo-Isar-Amper-Klinikum München-Ost, Ringstraße 10, 85540 Haar